Hemorrhage clinical trials at University of California Health

3 in progress, 0 open to eligible people

Showing trials for

  • Empiric Calcium in Massive Transfusion

    Sorry, not yet accepting patients

    Calcium helps blood to clot and thereby stop bleeding. Trauma patients who experience large volume blood loss often require blood transfusions and bleeding is the most common cause of death. The purpose of this study is to see if giving intravenous calcium immediately to patients who require large volume blood transfusion will decrease transfusion requirements, vasopressor use and mortality in bleeding trauma patients.

    at UC Irvine

  • Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: An Efficacy Study

    Sorry, not yet accepting patients

    Trauma is the leading cause of death and disability in children in the United States. The objective of this study is to evaluate the benefits and harms of tranexamic acid (TXA; a drug that stops bleeding) in severely injured children with hemorrhagic brain and/or torso injuries. Using thromboelastography, we will measure baseline fibrinolysis to assess for treatment effects of TXA at different levels of fibrinolysis.

    at UC Davis

  • Obsidio™ Conformable Embolic Registry

    Sorry, not currently recruiting here

    OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.

    at UCLA

Our lead scientists for Hemorrhage research studies include .

Last updated: